BGM Group Ltd. Class A Ordinary Shares (BGM) Stock Price

BGMStock

$8.65−96.93%52W

Market Cap$115.51M

P/E—

PEG Ratio—

Div yield—

Beta1.91

BGM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-26.25%

Price vs S&P 500 (4W)13.96%

VGM Score46.08

P/CF (Annual)232.17x

Book Value / Share (Quarterly)$1.95

P/TBV (Annual)4.31x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-16.38%

Cash Flow / Share (Quarterly)$-0.02

Price vs S&P 500 (YTD)-104.11%

Gross Margin (TTM)16.64%

Net Profit Margin (TTM)-52.59%

EPS (TTM)$-0.13

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-0.13

Revenue Growth (5Y)-5.39%

EPS (Annual)$-0.18

ROI (Annual)-5.08%

Gross Margin (Annual)16.64%

Net Profit Margin (5Y Avg)-13.58%

Cash / Share (Quarterly)$0.05

Revenue Growth QoQ (YoY)88.33%

ROA (Last FY)-4.60%

Revenue Growth TTM (YoY)51.09%

EBITD / Share (TTM)$-0.10

ROE (5Y Avg)-3.78%

Operating Margin (TTM)-33.18%

Cash Flow / Share (Annual)$-0.02

P/B Ratio0.30x

P/B Ratio (Quarterly)4.26x

Net Income / Employee (Annual)$-61,700

Net Interest Coverage (TTM)-1.48x

ROA (TTM)-6.22%

EPS Incl Extra (Annual)$-0.18

Current Ratio (Annual)1.24x

Quick Ratio (Quarterly)0.67x

3-Month Avg Trading Volume0.01M

52-Week Price Return-96.93%

Revenue / Employee (TTM)$117,400

Tangible BV / Share (Quarterly)$1.93

P/S Ratio (Annual)3.05x

Asset Turnover (Annual)0.09x

52-Week High$303.00

Operating Margin (5Y Avg)-6.72%

EPS Excl Extra (Annual)$-0.18

CapEx CAGR (5Y)29.70%

26-Week Price Return-16.34%

Quick Ratio (Annual)0.67x

13-Week Price Return2.37%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.24x

Enterprise Value$107.31M

Revenue / Share Growth (5Y)-25.20%

Asset Turnover (TTM)0.12x

Revenue / Employee (Annual)$117,400

Inventory Turnover (Annual)2.51x

Pretax Margin (Annual)-52.58%

Cash / Share (Annual)$0.05

3-Month Return Std Dev84.22%

Gross Margin (5Y Avg)11.26%

Net Income / Employee (TTM)$-61,700

EBITDA CAGR (5Y)-38.03%

ROE (Last FY)-5.10%

Net Interest Coverage (Annual)-1.48x

EPS Basic Excl Extra (Annual)$-0.18

P/FCF (TTM)712.30x

Receivables Turnover (TTM)13.08x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.13

Receivables Turnover (Annual)13.08x

ROI (TTM)-6.92%

P/S Ratio (TTM)3.05x

Pretax Margin (5Y Avg)-13.96%

Revenue / Share (Annual)$0.33

Tangible BV / Share (Annual)$1.93

Price vs S&P 500 (52W)-112.46%

Year-to-Date Return-92.19%

5-Day Price Return-15.20%

EPS Normalized (Annual)$-0.18

ROA (5Y Avg)-3.33%

Net Profit Margin (Annual)-52.59%

Month-to-Date Return14.57%

EBITD / Share (Annual)$-0.10

Operating Margin (Annual)-33.18%

ROI (5Y Avg)-3.89%

EPS Basic Excl Extra (TTM)$-0.13

P/TBV (Quarterly)4.31x

P/B Ratio (Annual)4.26x

Inventory Turnover (TTM)2.51x

Pretax Margin (TTM)-52.58%

Book Value / Share (Annual)$1.95

Price vs S&P 500 (13W)-0.32%

Beta1.91x

P/FCF (Annual)12.30x

Revenue / Share (TTM)$0.19

ROE (TTM)-6.96%

52-Week Low$6.45

vGradeC

gGradeC

mGradeD

vgmGradeC

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
BGMBGM Group Ltd. Class A Ordinary Shares	C	C	D	3.0x	51.1%	16.6%	—	$8.65
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About BGM Group Ltd. Class A Ordinary Shares

BGM Group Ltd manufactures pharmaceutical active ingredients and medical products through biopharmaceutical and bio-extraction operations. Its core revenue comes from oxytetracycline APIs, licorice preparations, and traditional Chinese medicine derivatives (TCMD), with secondary contributions from crude heparin sodium and specialty sausage casings. The company specializes in producing essential pharmaceutical intermediates for the healthcare industry.